Orthofix Medical Inc.OFIXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+10.3%
5Y CAGR+11.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+10.3%/yr
vs +10.2%/yr prior
5Y CAGR
+11.0%/yr
Consistent
Acceleration
+0.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$65.85M-10.6%
2024$73.64M-8.2%
2023$80.23M+63.5%
2022$49.06M-1.1%
2021$49.62M+27.1%
2020$39.06M+12.8%
2019$34.64M+4.3%
2018$33.22M+11.8%
2017$29.70M+3.1%
2016$28.80M-